Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
01/02/2008 | CN101098632A Composition composed of highly dispersible cellulose complex and polysaccharide |
01/02/2008 | CN101095956A Scutellarin prodrug using carboxymethyl chitosan as the carrier and method for preparing the same |
01/02/2008 | CN101095955A Scutellarin prodrug using poly-aspartate derivant as the carrier and method for preparing the same |
01/02/2008 | CN101095954A Transparent water oil-packaging type micro-emulsion stroma and method for preparing the same |
01/02/2008 | CN101095952A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies |
01/02/2008 | CN101095944A Sustained-releasing paster for preventing and treating prostatitis acupuncture points and the method for preparing the same and the use thereof |
01/02/2008 | CN101095942A Formulation of the Exendin injection medicine containing stabilizing agent |
01/02/2008 | CN101095929A Chinese traditional medicine ointment for treating hyperosteogeny and its method for making the same |
01/02/2008 | CN101095889A Plaster for treating ache and method for preparing the same |
01/02/2008 | CN101095764A Health-care food having assisted function of treating female urinary tract taint |
01/02/2008 | CN101095735A Chinese traditional medicine soft capsules for relieving cough and method for preparing the same |
01/02/2008 | CN101095722A Eye drops and preparation method thereof |
01/02/2008 | CN101095702A Graininess medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
01/02/2008 | CN101095701A Flaky medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
01/02/2008 | CN101095695A Liposome artificial tear eye drops |
01/02/2008 | CN101095693A Compound recipe medicine for treating dermatitis |
01/02/2008 | CN101095686A Method for producing lecithin capsule, lin ester alcohols and lecithin oral liquid |
01/02/2008 | CN101095684A Prunol phospholipid complexes and method for preparing the same and the application thereof |
01/02/2008 | CN101095681A Alfuzosin Hydrochloride permeating pump type controlled-release preparation and method for preparing the same |
01/02/2008 | CN101095679A Granisetron hydrochloride orally disintegrating tablets |
01/02/2008 | CN101095670A Luteolin phospholipid complexes and method for preparing the same and application thereof |
01/02/2008 | CN101095669A Osthole phospholipid complexes and method for preparing the same and application thereof |
01/02/2008 | CN101095666A Novel hydrochloric acid tramadol sustained-release tablet |
01/02/2008 | CN101095664A Phosphatide compound of resveratrol compounds and method for preparing the same and the application thereof |
01/02/2008 | CN101095663A Nicergoline sustained-release capsules and method for preparing the same |
01/02/2008 | CN101095661A Isosorbide mononitrate orally disintegrating tablets |
01/02/2008 | CN101095659A Liposome combined medicine and method for preparing the same |
01/02/2008 | CN101095658A Policresulen gelling agent, method for preparation the same and the pharmaceutical use thereof |
01/02/2008 | CN101095654A Cosmetic or medical composition comprising a condensation polymer, the cosmetic processing method of using said composition, said condensation polymer and the method for preparing the same |
01/02/2008 | CN100358581C Drug- or gene-carrier composition having lowered hemagglutinin activity |
01/02/2008 | CN100358580C Pharmaceutical compositions |
01/02/2008 | CN100358579C Compositions and methods to improve oral absorption of antimicrobial agents |
01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
01/02/2008 | CN100358545C Freeze drying powder and injection preparation in use for invigorating pulse-beat, and preparation method |
01/02/2008 | CN100358528C Use of mometasone furoate for treating airway passage and lung diseases |
01/02/2008 | CN100358518C Pharmaceutical compositions containing terbinafin and use thereof |
01/02/2008 | CN100358511C Oil-soluble medicine degradable polymer microcapsule injecta and preparing method |
01/02/2008 | CN100358510C Preparation of floridean polysaccharide vegetable prandial fiber medicinal hard capsule |
01/02/2008 | CN100358509C Enteric and colonic delivery using HPMC capsules |
01/02/2008 | CN100358494C Inhalation system |
01/01/2008 | US7314956 A molecular carrier containing a central multivalent core and multiple adduct molecules bonded with core, wherein adduct represents adduct moieties which can be the same of different from one another and are residues of amino acids |
01/01/2008 | US7314638 Preparing method for controlled released type tablet tamsulosin HCL and the tablet thereof |
01/01/2008 | US7314636 Biodegradable injectable implants containing glycolic acid |
01/01/2008 | US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |
01/01/2008 | US7314627 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
01/01/2008 | US7314626 Peptide antibiotic conjugate for use in recognition and elimination of infections agents or neoplasms; antitumor agents; bactericides |
01/01/2008 | US7314613 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells |
12/27/2007 | WO2007149560A2 Fermentation and purification of actinomadura chromoprotein and related species |
12/27/2007 | WO2007148798A1 Reduced coenzyme q10-containing composition and method for producing the same |
12/27/2007 | WO2007148786A1 Stabilized solid preparation |
12/27/2007 | WO2007148772A1 Sugar-coated reparation of macrolide antibiotic |
12/27/2007 | WO2007148714A1 Implant using rifamycin derivative |
12/27/2007 | WO2007148474A1 Preparation for external application to skin containing triterpenic acid |
12/27/2007 | WO2007147902A2 Rehydratable pharmaceutical product |
12/27/2007 | WO2007147514A1 Tablets comprising candesartan cilexetil |
12/27/2007 | WO2007147445A2 Keratin-binding effector molecules, and method for the production thereof |
12/27/2007 | WO2007147372A2 Pharmaceutical composition for administration by injection |
12/27/2007 | WO2007127844A3 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye |
12/27/2007 | WO2007122624A3 Non-covalent complexes of bioactive agents with starch for oral delivery |
12/27/2007 | WO2007105027A8 Anticancer drugs conjugated to antibody via an enzyme cleavable linker |
12/27/2007 | WO2007052289A3 Novel dispersible tablet composition |
12/27/2007 | WO2006010360A3 Carrier for medicaments for obtaining oral bioavailability |
12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
12/27/2007 | US20070299540 Methods of making medical implants of poly (vinyl alcohol) hydrogel |
12/27/2007 | US20070299285 Triterpene-Containing Oleogel-Forming Agent, Triterpene-Containing Oleogel and Method for Producing a Triterpene-Containing Oleogel |
12/27/2007 | US20070299240 Biodegradable block copolymers with modifiable surface |
12/27/2007 | US20070299238 Biodegradable block copolymers with modifiable surface |
12/27/2007 | US20070299227 Biodegradable block copolymers with modifiable surface |
12/27/2007 | US20070299141 Novel self-reversible reverse microlatex process for preparing it and cosmetic and industrial uses thereof |
12/27/2007 | US20070298461 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
12/27/2007 | US20070298424 Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer |
12/27/2007 | US20070298149 Animal Feedstuff Dyeing and Animal Drugs |
12/27/2007 | US20070298125 Medical Solution, A Method For Producing Said Medical Solution And Use Thereof |
12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
12/27/2007 | US20070298121 Using compositions containing zinc ions, calcium ions, rubidium ions and/or potassium ions; modulates matrix metalloproteinases (MMPs), |
12/27/2007 | US20070298120 Photoreactive Compound Specifically Binding to Calcium Binding Proteins |
12/27/2007 | US20070298116 Amorphous, spray-dried powders having a reduced moisture content and a high long term stability |
12/27/2007 | US20070298111 Fine Particle-Containing Composition and Manufacturing Method Therefor |
12/27/2007 | US20070298095 Surface-Modified and Solubility-Improved Hard Capsule |
12/27/2007 | US20070298094 Medicinal Composition, Preparation and Combined Preparation |
12/27/2007 | US20070298089 Drug for External Use and Adhesive Patch |
12/27/2007 | US20070298083 Concentrated omega-3 fatty acids and mixtures containing them |
12/27/2007 | US20070298082 Method and devices for forming articles |
12/27/2007 | US20070298081 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs |
12/27/2007 | US20070298080 Strain of Lactobacillus Acidophilus Having Analgesic Properties in the Gastrointestinal System |
12/27/2007 | US20070298079 Food fortified with omega-3 fatty acids |
12/27/2007 | US20070298078 Water Soluble Article for Imparting Dietary Fiber to Bottled Water |
12/27/2007 | US20070298077 Consumable veterinary medicine delivery device |
12/27/2007 | US20070298076 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
12/27/2007 | US20070298066 Biodegradable linkers for molecular therapies |
12/27/2007 | US20070298058 Pharmaceutical compositions comprising ascomycin |
12/27/2007 | US20070298052 Drying Process for Presserving an Active Agent as a Higly Viscous Liquid |
12/27/2007 | US20070298048 Non-viral gene delivery system |
12/27/2007 | US20070298006 Dendritic Polymers With Enhanced Amplification and Interior Functionality |
12/27/2007 | US20070297979 Pharmaceutical Compounds |
12/27/2007 | DE4240430B4 Stabilisiertes pharmazeutisches Mittel, enthaltend einen HMG-CoA-Reduktase-Inhibitor Wirkstoff A stabilized pharmaceutical composition comprising an HMG-CoA reductase inhibitor active agent |
12/27/2007 | DE102006029233A1 Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika Formulations to improve the compatibility of non-steroidal anti-inflammatory drugs |
12/27/2007 | DE102006028780A1 Producing porous silicon body with lens-shaped structure comprises applying the lens-like photolacquer coat, transferring the coat shape to the silicon surface by etching, masking silicon surface and porosing the non-masked silicon surface |
12/27/2007 | DE10033990B4 Nanopartikel aus einem substituierten Cyclodextrin, dessen Verwendung und diese enthaltenden Zubereitungen Nanoparticles consisting of a substituted cyclodextrin, its use and these preparations containing |
12/27/2007 | CA2743725A1 Stabilizing alkylglycoside compositions and methods thereof |